Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | NAMPT | P43490 | 1/20 | 0.34 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4849807 | 0.91 | KMT2A (0.49) | ALDH1A1EPHX2KMT2AMEN1TSHR | |
| SCHEMBL1197607 | 0.89 | ALDH1A1 (0.65) | ALDH1A1KMT2ATSHRL3MBTL1SMN1; SMN2 | |
| SCHEMBL2608239 | 0.87 | ALDH1A1 (0.58) | ALDH1A1EPHX2KMT2ATSHRL3MBTL1 | |
| SCHEMBL2608244 | 0.86 | ALDH1A1 (0.57) | ALDH1A1EPHX2KMT2ATSHRL3MBTL1 | |
| SCHEMBL24933071 | 0.83 | ALDH1A1 (0.40) | ALDH1A1EPHX2KMT2AMEN1TSHR | |
| SCHEMBL11585774 | 0.82 | MEN1 (0.36) | ALDH1A1EPHX2KMT2AMEN1TSHR | |
| SCHEMBL12036308 | 0.81 | MEN1 (0.47) | ALDH1A1EPHX2KMT2AMEN1TSHR | |
| SCHEMBL855074 | 0.80 | TGFBR1 (0.37) | ALDH1A1KMT2AMEN1TSHRSMN1; SMN2 | |
| SCHEMBL13862904 | 0.79 | MEN1 (0.50) | ALDH1A1EPHX2KMT2AMEN1TSHR | |
| SCHEMBL23841863 | 0.79 | EPHX2 (0.40) | ALDH1A1EPHX2KMT2AMEN1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260040695-A1 | A METHOD TO GENERATE CONDUCTIVE POLYMER | NEWSOUTH INNOVATIONS PTY LTD (AU) | 2026-02-05 | — | — | US | claimed |
| WO-2024020649-A1 | A METHOD TO GENERATE CONDUCTIVE POLYMER | NEWSOUTH INNOVATIONS PTY LIMITED (AU) | 2024-02-01 | — | — | WO | claimed |
| WO-2022261721-A1 | HEALABLE AND REPROCESSABLE COMPOSITIONS | DEAKIN UNIVERSITY (AU) | 2022-12-22 | — | — | WO | claimed |
| EP-2267048-B1 | FLUOROPOLYMER AND WATER-REPELLENT AND OIL-REPELLENT AGENT | DAIKIN IND LTD (JP) | 2016-10-12 | — | — | EP | claimed |
| EP-2267048-A1 | FLUOROPOLYMER AND WATER-REPELLENT AND OIL-REPELLENT AGENT | Daikin Industries, Ltd. (JP) | 2010-12-29 | — | — | EP | claimed |
| US-7329694-B2 | Ocular lens | JOHNSON & JOHNSON VISION CARE, INC. (US) | 2008-02-12 | — | — | US | claimed |
| JP-6306122-A | — | — | None | — | — | JP | disclosed |
| US-20260040695-A1 | A METHOD TO GENERATE CONDUCTIVE POLYMER | NEWSOUTH INNOVATIONS PTY LTD (AU) | 2026-02-05 | — | — | US | disclosed |
| EP-3665172-B1 | COMPOUNDS AS POTENTIAL DYE MOLECULES | Lleaf Pty Ltd (AU) | 2025-03-19 | — | — | EP | disclosed |
| WO-2024020649-A1 | A METHOD TO GENERATE CONDUCTIVE POLYMER | NEWSOUTH INNOVATIONS PTY LIMITED (AU) | 2024-02-01 | — | — | WO | disclosed |
| WO-2022261721-A1 | HEALABLE AND REPROCESSABLE COMPOSITIONS | DEAKIN UNIVERSITY (AU) | 2022-12-22 | — | — | WO | disclosed |
| US-20220306836-A1 | PHOTOPERIODIC CONTROL OF PHYTOCHROME WITH MATERIALS | Lleaf Pty Ltd (AU) | 2022-09-29 | — | — | US | disclosed |
| US-11345180-B2 | Display medium for assessment and method for manufacturing same | ZEON CORPORATION (JP) | 2022-05-31 | — | — | US | disclosed |
| US-6682662-B2 | MIXTURE OF TRANSPARENT POLYER AND BRIGHTENER AGENT | FUJI PHOTO FILM CO., LTD. (JP) | 2004-01-27 | — | — | US | disclosed |
| EP-0704217-B1 | Vascular embolizing agent | NAT INST OF ADVANCED IND SCIEN (JP) | 2002-11-20 | — | — | EP | disclosed |
| US-20020040976-A1 | Fluorescent lamp cover and lighting fixture | FUJI PHOTO FILM CO., LTD. | 2002-04-11 | — | — | US | disclosed |
| EP-1178076-A1 | Fluorescent lamp cover and lighting fixture | Fuji Photo Film Co., Ltd. (JP) | 2002-02-06 | — | — | EP | disclosed |
| US-5525334-A | Method for vascular embolization | JAPAN AS REPRESENTED BY DIRECTOR GENERAL OF AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 1996-06-11 | — | — | US | disclosed |
| EP-0704217-A2 | Method for vascular embolization and vascular embolizing agent | JAPAN as represented by DIRECTOR GENERAL OF AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 1996-04-03 | — | — | EP | disclosed |
| JP-H06306122-A | HEAT-SENSITIVE HIGH-MOLECULAR COMPOUND AND MANUFACTURE THEREOF | AGENCY OF IND SCIENCE & TECHNOL | 1994-11-01 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260040695-A1 | A METHOD TO GENERATE CONDUCTIVE POLYMER | PIEZO1, LCP1, MTCL3 | ALDH1A1 4717/4885EPHX2 3072/4885KMT2A 2492/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.